3.0
Jun 19, 2015
Recommend
CEO approval
Business Outlook
Pros
Company had a great culture and really great sales people. Products treated underserved Orphan diseases.
Cons
Sanofi buy-out ruined the culture. As time went on, Genzyme became less Genzyme and more big Pharma